Not applicableNo Longer AvailableNCT03906344What this trial is testingExpanded Access Use of INCB052793 to Treat a Single Patient With Myelofibrosis Incyte Corporation
Early research (Phase 1)Active Not RecruitingNCT04328844What this trial is testingAssess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic CancersWho this might be right forSolid Tumor, AdultNon-Hodgkin Lymphoma, AdultNSCLC+2 more iOnctura 210
Testing effectiveness (Phase 2)Study completedNCT02396134What this trial is testingVaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+11 more City of Hope Medical Center 61
Not applicableStudy completedNCT02953704What this trial is testingMyelofibrosis and Essential Thrombocythemia Observational Study (MOST)Who this might be right forMPN (Myeloproliferative Neoplasms) Incyte Corporation 1,469
Not applicableLooking for participantsNCT05093881What this trial is testingLong-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LCWho this might be right forAlcoholic Liver Cirrhosis Pharmicell Co., Ltd. 100
Testing effectiveness (Phase 2)Looking for participantsNCT05980806What this trial is testingSelinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate ThrombocytopeniaWho this might be right forMyelofibrosisModerate ThrombocytopeniaMild Thrombocytopenia Karyopharm Therapeutics Inc 58
Early research (Phase 1)UnknownNCT03838250What this trial is testingStudy to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LCWho this might be right forAlcoholic Liver Cirrhosis Pharmicell Co., Ltd. 10
Not applicableNot Yet RecruitingNCT07518940What this trial is testingENERGIA: Personalized Exercise Program for Fatigue in Patients With Myeloproliferative Neoplasms and Chronic Myeloid LeukemiaWho this might be right forMyeloproliferative DiseasePolycythemia VeraThrombocythemia Essential+2 more Carmen Fava 25
Early research (Phase 1)Active Not RecruitingNCT04041050What this trial is testingA Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmWho this might be right forMyeloproliferative Neoplasm AbbVie 85
Early research (Phase 1)Active Not RecruitingNCT05233618What this trial is testingStudy of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)Who this might be right forMyelofibrosisChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia Karen Ballen, MD 44
Large-scale testing (Phase 3)UnknownNCT01316744What this trial is testingKetamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic PainWho this might be right forCancer University of Glasgow 214
Early research (Phase 1)Study completedNCT00953758What this trial is testingPF-04449913 In Select Hematologic MalignanciesWho this might be right forHematologic Malignancies Pfizer 47
Early research (Phase 1)Active Not RecruitingNCT06313593What this trial is testingEvaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative NeoplasmsWho this might be right forMyeloproliferative Neoplasms Incyte Corporation 37
Testing effectiveness (Phase 2)Study completedNCT00039416What this trial is testingImatinib Mesylate in Treating Patients With MyelofibrosisWho this might be right forChronic Myelomonocytic LeukemiaEssential ThrombocythemiaPolycythemia Vera+1 more National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Ended earlyNCT00382278What this trial is testingSafety Study of Autologous Stem Cell in Liver CirrhosisWho this might be right forLiver Cirrhosis Universidade Federal do Rio de Janeiro 15
Testing effectiveness (Phase 2)Study completedNCT00005804What this trial is testingBone Marrow Transplantation in Treating Patients With Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01348490What this trial is testingRuxolitinib (INCB018424) in Participants With Primary Myelofibrosis (PMF), Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis (PPV-MF)Who this might be right forMPN (Myeloproliferative Neoplasms) Incyte Corporation 66
Early research (Phase 1)Study completedNCT00462761What this trial is testingA Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 StatusWho this might be right forAcute Myeloid LeukemiaLeukemiaMyelodysplastic Syndrome+2 more Daiichi Sankyo 76
Not applicableActive Not RecruitingNCT04217356What this trial is testingStudy of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk MyelofibrosisWho this might be right forMyelofibrosisHigh-Risk CancerBone Marrow Cancer University Health Network, Toronto 90
Testing effectiveness (Phase 2)Looking for participantsNCT07394153What this trial is testingPacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have ThrombocytopeniaWho this might be right forMyelofibrosis，MF Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas 30